A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to ...

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...

As the popularity of injectable weight-loss drugs continues to rise, a new study by the Cleveland Clinic has offered a more nuanced understanding of what happens when patients discontinue these ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

With obesity rates hovering around one in three adults, looser pricing could make semaglutide standard of care ...

Spain: A new study has found that treatment with Semaglutide in patients with Hidradenitis Suppurativa and obesity led to ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

California is denying popular and effective weight loss drugs to poor people — likely to spite President Donald Trump, who ...

Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those ...